Home

4D Molecular Therapeutics, Inc. - Common Stock (FDMT)

5.3150
-0.6550 (-10.97%)

4D Molecular Therapeutics Inc is a biotechnology company focused on developing innovative gene therapies that leverage its proprietary platform technology

The company aims to create targeted and effective treatment options for a range of serious diseases by designing and delivering therapeutic genes directly to specific tissues, thereby enhancing the efficacy and safety of gene-based treatments. Through its commitment to advancing molecular medicine, 4D Molecular Therapeutics works to address unmet medical needs and improve patient outcomes by harnessing the power of the body's own biology.

SummaryNewsPress ReleasesChartHistoricalFAQ

Frequently Asked Questions

Is 4D Molecular Therapeutics, Inc. - Common Stock publicly traded?
Yes, 4D Molecular Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does 4D Molecular Therapeutics, Inc. - Common Stock trade on?
4D Molecular Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for 4D Molecular Therapeutics, Inc. - Common Stock?
The ticker symbol for 4D Molecular Therapeutics, Inc. - Common Stock is FDMT on the Nasdaq Stock Market
What is the current price of 4D Molecular Therapeutics, Inc. - Common Stock?
The current price of 4D Molecular Therapeutics, Inc. - Common Stock is 5.315
When was 4D Molecular Therapeutics, Inc. - Common Stock last traded?
The last trade of 4D Molecular Therapeutics, Inc. - Common Stock was at 4:00 pm EST on February 10th, 2025
What is the market capitalization of 4D Molecular Therapeutics, Inc. - Common Stock?
The market capitalization of 4D Molecular Therapeutics, Inc. - Common Stock is 223.51M
How many shares of 4D Molecular Therapeutics, Inc. - Common Stock are outstanding?
4D Molecular Therapeutics, Inc. - Common Stock has 42.05M shares outstanding.